Travere Therapeutics Inc (TVTX)
R&D Expenses
$227.14M
TTM · Period ending: · USD
TVTX R&D Expenses
Latest reported$227.14Mperiod ending
Latest reported$227.14Mperiod ending
TVTX TTM R&D Expenses ($0.00 → $227.14M)
TTM R&D Expenses
High-resolution chart · PNG
TVTX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 227,137,000 | |
| 216,216,000 | |
| 206,011,000 | |
| 210,208,000 | |
| 209,997,000 | |
| 214,965,000 | |
| 282,701,000 | |
| 279,383,000 | |
| 288,294,000 | |
| 300,456,000 | |
| 245,744,000 | |
| 247,227,000 | |
| 243,782,000 | |
| 236,971,000 | |
| 233,669,000 | |
| 235,605,000 | |
| 226,867,000 | |
| 218,993,000 | |
| 210,328,000 | |
| 186,546,000 | |
| 170,488,000 | |
| 149,471,000 | |
| 131,774,000 | |
| 129,462,000 | |
| 130,333,000 | |
| 137,477,000 | |
| 140,671,000 | |
| 136,592,000 | |
| 135,820,000 | |
| 132,346,000 | |
| 123,539,000 | |
| 111,120,000 | |
| 98,282,000 | |
| 83,304,000 | |
| 79,528,000 | |
| 80,030,000 | |
| 78,848,000 | |
| 77,041,000 | |
| 70,853,000 | |
| 66,227,000 | |
| 61,863,000 | |
| 54,751,000 | |
| 50,425,456 | |
| 49,165,233 | |
| 48,119,962 | |
| 51,254,953 | |
| 47,795,223 | |
| 38,573,642 | |
| 26,954,788 | |
| 13,862,000 | |
| 7,133,964 | |
| 2,539,381 | |
| 1,250,162 | |
| 644,959 | |
| 486,269 | |
| 110,656 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |